Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
12 hedge funds and large institutions have $1.14M invested in Vaccinex, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
61% more capital inflows, than outflows
Capital inflows: $695K | Capital outflows: $430K
9% more funds holding
Funds holding: 11 → 12 (+1)
0.99% less ownership
Funds ownership: 20.39% → 19.39% (-0.99%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
+$394K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$278K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$19.1K |
| 4 |
Tower Research Capital (TRC)
New York
|
+$3.15K |
| 5 |
Barclays
London,
United Kingdom
|
+$152 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$424K |
| 2 |
Morgan Stanley
New York
|
-$6.24K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$11 |
VCNX Hedge Fund Activity: Q3 2024 in Review
12 of the 6,983 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q3 2024, worth a combined $1.14M — down 37% from $1.81M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new VCNX positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Armistice Capital, adding an estimated $394K. The largest seller was AIGH Capital Management, exiting entirely with an estimated $424K sold.
- 12 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q3 2024, up from 11 in Q2 2024.
- Funds reported $1.14M of Vaccinex, Inc. Common Stock stock for Q3 2024, down 37% quarter-over-quarter.
- 2 funds opened new Vaccinex, Inc. Common Stock positions in Q3 2024 and 1 closed out, a net change of +1 holder.
- The largest Vaccinex, Inc. Common Stock buyer in Q3 2024 was Armistice Capital, an estimated $394K added.
- The largest Vaccinex, Inc. Common Stock seller in Q3 2024 was AIGH Capital Management, an estimated $424K sold.
Based on aggregated 13F filings for Q3 2024.